Document is current
Any future updates will be listed below
-
Authors
Nacov, Julia A. https://orcid.org/0000-0002-5327-2937
Stemler, Jannik https://orcid.org/0000-0001-9152-2469
Salmanton-García, Jon https://orcid.org/0000-0002-6766-8297
Cremer, Louise M. https://orcid.org/0009-0002-1425-7352
Zeitlinger, Markus https://orcid.org/0000-0002-1873-3953
Mallon, Patrick W. G. https://orcid.org/0000-0002-4337-6222
Pana, Zoi Dorothea https://orcid.org/0000-0002-5893-1081
Schmitt, Heinz-Josef https://orcid.org/0000-0002-0378-5697
Cornely, Oliver A. https://orcid.org/0000-0001-9599-3137
,
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 14 February 2024
Accepted: 13 May 2024
First Online: 28 May 2024
Declarations
:
: HJS has received consultancy or speaker honoraria from Pfizer, CSL Seqirus, Sanofi, Cologne University, Global Health Press, Minervax, VacciZONE and GOPA/KfW. JAN has received speaker honoraria by Hikma. JSG has received speaker honoraria from Gilead and Pfizer. JS has received research grants by the Ministry of Education and Research (BMBF) and Basilea Pharmaceuticals Inc.; has received speaker honoraria by Pfizer Inc., Gilead, Hikma and AbbVie; has been a consultant to Gilead, Alvea Vax. and Micron Research. PWGM has received honoraria and/or travel grants from Astrazeneza, Gilead Sciences, ViiV, Janssen and Pfizer. OAC reports grants or contracts from Amplyx, Basilea, BMBF, Cidara, DZIF, EU-DG RTD (101037867), F2G, Gilead, Matinas, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; Consulting fees from Abbvie, Amplyx, Biocon, Biosys, Cidara, Da Volterra, Gilead, IQVIA, Janssen, Matinas, MedPace, Menarini, Molecular Partners, MSG-ERC, Noxxon, Octapharma, Pardes, Pfizer, PSI, Scynexis, Seres; Honoraria for lectures from Abbott, Abbvie, Al-Jazeera Pharmaceuticals, Astellas, Gilead, Grupo Biotoscana/United Medical/Knight, Hikma, MedScape, MedUpdate, Merck/MSD, Mylan, Noscendo, Pfizer, Shionogi; Payment for expert testimony from Cidara; Participation on a Data Safety Monitoring Board or Advisory Board from Actelion, Allecra, Cidara, Entasis, IQVIA, Janssen, MedPace, Paratek, PSI, Pulmocide, Shionogi, The Prime Meridian Group; A patent at the German Patent and Trade Mark Office (DE 10 2021 113 007.7); Stocks from CoRe Consulting, and EasyRadiology. LMC, MZ and ZDP have nothing to declare.
